IP Library Granted Patent US 8,226,603
Granted Patent B2
US 8,226,603 · App. 12/237,998 · Granted Jul 24, 2012

Expandable member having a covering formed of a fibrous matrix for intraluminal drug delivery

Assignee: Abbott Cardiovascular Systems Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,226,603
App. No.
12/237,998
Granted
Jul 24, 2012
Kind
B2
Abstract

The present invention generally relates to an intraluminal catheter device for use in angioplasty and delivery of a therapeutic agent. Particularly, the present invention is directed to a catheter having an expandable member having a therapeutic agent disposed thereon and a fibrous matrix covering for delivering a therapeutic agent and methods of using the same.

Claims (21)

1. An intraluminal catheter device comprising:

an elongated catheter shaft having a proximal end portion and a distal end portion, the shaft having an inflation lumen disposed between the proximal end portion and the distal end portion;

an expandable member having an outer surface and an inner surface disposed proximate to the distal end portion of the catheter shaft, the expandable member having a coating of at least one therapeutic agent disposed on at least a portion of the outer surface; and

a covering having a proximal end portion and a distal end portion, the covering positioned over at least a portion of the therapeutic agent coating on the outer surface of the expandable member, the covering formed of a matrix of fiber elements and attached to the catheter device by an attachment consisting of a bond at one of either the proximal end portion to a portion of the expandable member that is generally cylindrical after expansion of the expandable member or the distal end portion of the covering to a portion of the expandable member that is generally cylindrical after expansion of the expandable member.

2. The device of claim 1 , wherein the matrix of fiber elements of the covering is formed of electrospun fiber elements.

3. The device of claim 1 , wherein the fiber elements comprise a polymer selected from the group consisting of polyamides, polyurethanes, fluoropolymers, polyolefins, polyimides, polyimines, (methyl)acrylic polymers, polyesters, and co-polymers thereof.

4. The device of claim 1 , wherein the attachment consists of the bond at the proximal end portion of the covering.

5. The device of claim 1 , wherein the attachment consists of a bond at the distal end portion of the covering.

6. The device of claim 1 , wherein the bond attaches the covering to the catheter shaft.

7. The device of claim 1 , wherein the bond is selected from the group consisting of adhesion, thermal welding, heat shrink bands and direct solvent bonding.

8. The device of claim 1 , wherein at least one of the proximal or distal end portions of the covering has a tapered end.

9. The device of claim 1 , wherein the covering is essentially free of the at least one therapeutic agent.

10. The device of claim 1 , wherein the matrix of fibers of the covering is relatively tightly woven to prevent the at least one therapeutic agent from entering between the fibers.

11. The device of claim 1 , wherein the outer surface of the expandable member is textured to include a plurality of voids.

12. The device of claim 11 , wherein the size of the voids ranges from 1 nanometer to 1 micron.

13. The device of claim 11 , wherein the therapeutic agent of the therapeutic agent coating is loaded within the plurality of voids.

14. The device of claim 1 , wherein the at least one therapeutic agent is selected from the group consisting of anti-proliferative, anti-inflammatory, antineoplastic, antiplatelet, anti-coagulant, anti-fibrin, antithrombonic, antimitotic, antibiotic, antiallergic and antioxidant compounds and combinations thereof.

15. The device of claim 1 , wherein the expandable member is expandable from a first profile to a second profile.

16. The device of claim 1 , wherein the matrix of fiber elements defines a plurality of gaps between the fibers.

17. The device of claim 1 , wherein the covering formed of a matrix of fiber elements is separately formed and is slipped over the therapeutic agent coating on the outer surface of the expandable member.

18. The device of claim 1 , wherein the covering formed of a matrix of fiber elements is formed directly over the therapeutic agent coating on the outer surface of the expandable member.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2009
From: OEPEN, RANDOLF VON; STANKUS, JOHN; STAMBERG, BARBARA; YRIBARREN, TRAVIS R.; NEWHAUSER, RICHARD R.
To: ABBOTT CARDIOVASCULAR SYSTEMS INC.
Reel/Frame 022111/0786 →
Continuity (1)
Related Publication 20100076401A1 · Mar 25, 2010